SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000860
Filing Date
2021-08-05
Accepted
2021-08-05 07:16:35
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrr-20210630.htm   iXBRL 10-Q 2517875
2 EX-31.1 tcrr-20210630ex31_1.htm EX-31.1 15954
3 EX-31.2 tcrr-20210630ex31_2.htm EX-31.2 15963
4 EX-32.1 tcrr-20210630ex32_1.htm EX-32.1 12765
5 GRAPHIC img15119486_0.jpg GRAPHIC 167882
  Complete submission text file 0000950170-21-000860.txt   8639031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrr-20210630_cal.xml EX-101.CAL 52469
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrr-20210630_def.xml EX-101.DEF 161810
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20210630_lab.xml EX-101.LAB 421220
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20210630_pre.xml EX-101.PRE 304118
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20210630.xsd EX-101.SCH 47145
11 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-20210630_htm.xml XML 1496187
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38811 | Film No.: 211146289
SIC: 2836 Biological Products, (No Diagnostic Substances)